{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:41:53Z","timestamp":1752669713483},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"19","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2019,9,13]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>&lt;P&gt;Diabetes Mellitus (DM) is now a well-known factor which initiates many metabolic derangements in\nvarious tissues and organs including liver, muscle, pancreas, adipose tissue, cardiovascular and nervous system.\nCardiovascular complications are the most crucial , and their effects are so intensive that their derangement leads\nto cardiac failure even in the absence of ischemic heart diseases. This entity of cardiac pathology in DM is often\nregarded as diabetic cardiomyopathy (DCM). Recently, many plant-derived drugs have been tested to control and\nalleviate DCM. Wogonin is one of the drugs the characteristics of which have been deeply studied. Wogonin is a\nflavonoid having yellow color pigment in their leaves and is obtained from the roots of plant Scutellaria Baicalensis\nGeorgi. Wogonin has long been used as an active anti-cancer drug in Chinese medicine practice. In recent\npast wogonin has shown to possess notable anti-inflammatory, and anti-allergic properties. Wogonin has\ndemonstrated to possess anti-oxidant, anti-viral, anti-inflammatory and also anti-thrombotic properties.\n&lt;\/P&gt;&lt;P&gt;\nWogonin has shown to alleviate apoptosis, and ER stress in the cells and this property can also be used in the\ntreatment of cardiovascular diseases. Notably, wogonin has been documented to have an extensive margin of\nsafety as well as displays little or no organ toxicity following extended intravenous administration. In this review,\nwe discuss recently discovered therapeutic potential of wogonin in the treatment of DCM.&lt;\/P&gt;<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612825666190708173108","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:40:55Z","timestamp":1562672455000},"page":"2171-2177","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?"],"prefix":"10.2174","volume":"25","author":[{"given":"Shahzad","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, Wuhan University School of Medicine, Hubei, Wuhan V, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Kamal","sequence":"additional","affiliation":[{"name":"King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"507","volume":"60","author":"Chang Y-L.","year":"2001","unstructured":"Chang Y-L.; Shen J-J.; Wung B-S.; Cheng J-J.; Wang D.L.; Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 2001,60(3),507-513","journal-title":"Mol Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","volume":"332","author":"Li-Weber M.","year":"2013","unstructured":"Li-Weber M.; Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett 2013,332(2),304-312","journal-title":"Cancer Lett"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00280-010-1396-8","volume":"67","author":"Enomoto R.","year":"2011","unstructured":"Enomoto R.; Koshiba C.; Suzuki C.; Lee E.; Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. Cancer Chemother Pharmacol 2011,67(5),1063-1072","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10753-014-0013-0","volume":"38","author":"Lee W.","year":"2015","unstructured":"Lee W.; Ku S.K.; Bae J.S.; Anti-inflammatory effects of Baicalin, Baicalein, and Wogonin in vitro and in vivo. Inflammation 2015,38(1),110-125","journal-title":"Inflammation"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","volume":"36","author":"Maisch B.","year":"2011","unstructured":"Maisch B.; Alter P.; Pankuweit S.; Diabetic cardiomyopathy--fact or fiction? Herz 2011,36(2),102-115","journal-title":"Herz"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10741-013-9374-y","volume":"19","author":"Bodiga V.L.","year":"2014","unstructured":"Bodiga V.L.; Eda S.R.; Bodiga S.; Advanced glycation end products: Role in pathology of diabetic cardiomyopathy. Heart Fail Rev 2014,19(1),49-63","journal-title":"Heart Fail Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2337\/diabetes.53.2.463","volume":"53","author":"Bidasee K.R.","year":"2004","unstructured":"Bidasee K.R.; Zhang Y.; Shao C.H.; Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca-ATPase. Diabetes 2004,53(2),463-473","journal-title":"Diabetes"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","volume":"25","author":"Xie J.","year":"2013","unstructured":"Xie J.; M\u00e9ndez J.D.; M\u00e9ndez-Valenzuela V.; Aguilar-Hern\u00e1ndez M.M.; Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal 2013,25(11),2185-2197","journal-title":"Cell Signal"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1124\/jpet.112.200808","volume":"345","author":"Jadhav A.","year":"2013","unstructured":"Jadhav A.; Tiwari S.; Lee P.; Ndisang J.F.; The heme oxygenase system selectively enhances the anti-inflammatory macrophage-M2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats. J Pharmacol Exp Ther 2013,345(2),239-249","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","volume":"87","author":"Frustaci A.","year":"2000","unstructured":"Frustaci A.; Kajstura J.; Chimenti C.; Myocardial cell death in human diabetes. Circ Res 2000,87(12),1123-1132","journal-title":"Circ Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diabetes.50.6.1414","volume":"50","author":"Kajstura J.","year":"2001","unstructured":"Kajstura J.; Fiordaliso F.; Andreoli A.M.; IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001,50(6),1414-1424","journal-title":"Diabetes"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.2337\/db08-0805","volume":"57","author":"Singh V.P.","year":"2008","unstructured":"Singh V.P.; Le B.; Khode R.; Baker K.M.; Kumar R.; Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 2008,57(12),3297-3306","journal-title":"Diabetes"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1677\/joe.0.1540355","volume":"154","author":"Brown L.","year":"1997","unstructured":"Brown L.; Wall D.; Marchant C.; Sernia C.; Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 1997,154(2),355-362","journal-title":"J Endocrinol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"Bugger H.","year":"2014","unstructured":"Bugger H.; Abel E.D.; Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 2014,57(4),660-671","journal-title":"Diabetologia"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"H153","DOI":"10.1152\/ajpheart.01142.2008","volume":"297","author":"Serpillon S.","year":"2009","unstructured":"Serpillon S.; Floyd B.C.; Gupte R.S.; Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am J Physiol Heart Circ Physiol 2009,297(1),H153-H162","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1475-2840-12-158","volume":"12","author":"Liu Z-W.","year":"2013","unstructured":"Liu Z-W.; Zhu H-T.; Chen K-L.; Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol 2013,12(1),158","journal-title":"Cardiovasc Diabetol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12986-015-0057-7","volume":"12","author":"Vinayagam R.","year":"2015","unstructured":"Vinayagam R.; Xu B.; Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutr Metab (Lond) 2015,12(1),60","journal-title":"Nutr Metab (Lond)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1142\/S0192415X96000050","volume":"24","author":"Lin C-C.","year":"1996","unstructured":"Lin C-C.; Shieh D-E.; The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 1996,24(1),31-36","journal-title":"Am J Chin Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2007-06-096198","volume":"111","author":"Baumann S.","year":"2008","unstructured":"Baumann S.; Fas S.C.; Giaisi M.; Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca-dependent apoptosis. Blood 2008,111(4),2354-2363","journal-title":"Blood"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1089\/ars.2009.2569","volume":"11","author":"Khan M.I.","year":"2009","unstructured":"Khan M.I.; Pichna B.A.; Shi Y.; Bowes A.J.; Werstuck G.H.; Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model. Antioxid Redox Signal 2009,11(9),2289-9","journal-title":"Antioxid Redox Signal"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0006-2952(99)00160-4","volume":"58","author":"Kim H.K.","year":"1999","unstructured":"Kim H.K.; Cheon B.S.; Kim Y.H.; Kim S.Y.; Kim H.P.; Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 1999,58(5),759-765","journal-title":"Biochem Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.221","volume":"5","author":"Yao J.","year":"2014","unstructured":"Yao J.; Zhao L.; Zhao Q.; NF-\u03baB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis. Cell Death Dis 2014,5","journal-title":"Cell Death Dis"},{"key":"ref=23","first-page":"31","volume":"41","author":"Huang Y.Q.","year":"2010","unstructured":"Huang Y.Q.; Wang X.; Kong W.; Diabetic cardiomyopathy. Sheng Li Ke Xue Jin Zhan 2010,41(1),31-36","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1254\/jphs.FP0061501","volume":"104","author":"Enomoto R.","year":"2007","unstructured":"Enomoto R.; Sugahara C.; Suzuki C.; Wogonin prevents glucocorticoid-induced thymocyte apoptosis without diminishing its anti-inflammatory action. J Pharmacol Sci 2007,104(4),355-365","journal-title":"J Pharmacol Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.cellsig.2012.07.019","volume":"24","author":"Lee D-H.","year":"2012","unstructured":"Lee D-H.; Lee T.H.; Jung C.H.; Kim Y-H.; Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells. Cell Signal 2012,24(11),2216-2225","journal-title":"Cell Signal"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/aps.2011.120","volume":"32","author":"Liu Y.M.","year":"2011","unstructured":"Liu Y.M.; Wang X.; Nawaz A.; Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway. Acta Pharmacol Sin 2011,32(12),1475-1482","journal-title":"Acta Pharmacol Sin"},{"key":"ref=27","first-page":"507","volume":"60","author":"Chang Y-L.","year":"2001","unstructured":"Chang Y-L.; Shen J-J.; Wung B-S.; Cheng J-J.; Wang D.L.; Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 2001,60(3),507-513","journal-title":"Mol Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00011-009-0037-3","volume":"58","author":"Garc\u00eda-Lafuente A.","year":"2009","unstructured":"Garc\u00eda-Lafuente A.; Guillam\u00f3n E.; Villares A.; Rostagno M.A.; Mart\u00ednez J.A.; Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm Res 2009,58(9),537-552","journal-title":"Inflamm Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1471-4159.2004.02682.x","volume":"90","author":"Wu C.Y.","year":"2004","unstructured":"Wu C.Y.; Hsieh H.L.; Jou M.J.; Yang C.M.; Involvement of p42\/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 2004,90(6),1477-1488","journal-title":"J Neurochem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12272-015-0671-y","volume":"39","author":"Oche B.","year":"2016","unstructured":"Oche B.; Chen L.; Ma Y.K.; Cryptotanshinone and wogonin up-regulate eNOS in vascular endothelial cells via ER\u03b1 and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via ER\u03b2. Arch Pharm Res 2016,39(2),249-258","journal-title":"Arch Pharm Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/FJC.0b013e31821a5078","volume":"58","author":"Lee Y-M.","year":"2011","unstructured":"Lee Y-M.; Cheng P-Y.; Chen S-Y.; Chung M-T.; Sheu J-R.; Wogonin suppresses arrhythmias, inflammatory responses, and apoptosis induced by myocardial ischemia\/reperfusion in rats. J Cardiovasc Pharmacol 2011,58(2),133-142","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yjmcc.2013.10.014","volume":"71","author":"Ouyang C.","year":"2014","unstructured":"Ouyang C.; You J.; Xie Z.; The interplay between autophagy and apoptosis in the diabetic heart. J Mol Cell Cardiol 2014,71,71-80","journal-title":"J Mol Cell Cardiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12986-015-0057-7","volume":"12","author":"Vinayagam R.","year":"2015","unstructured":"Vinayagam R.; Xu B.; Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutr Metab (Lond) 2015,12(1),60","journal-title":"Nutr Metab (Lond)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/aps.2015.37","volume":"36","author":"Zhang Y.M.","year":"2015","unstructured":"Zhang Y.M.; Li M.X.; Tang Z.; Wang C.H.; Wogonin suppresses osteopontin expression in adipocytes by activating PPAR\u03b1. Acta Pharmacol Sin 2015,36(8),987-997","journal-title":"Acta Pharmacol Sin"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10557-008-6144-5","volume":"23","author":"Mehta N.N.","year":"2009","unstructured":"Mehta N.N.; Sheetz M.; Price K.; Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus. Cardiovasc Drugs Ther 2009,23(1),17-24","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/aps.2011.120","volume":"32","author":"Liu Y.M.","year":"2011","unstructured":"Liu Y.M.; Wang X.; Nawaz A.; Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway. Acta Pharmacol Sin 2011,32(12),1475-1482","journal-title":"Acta Pharmacol Sin"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.bcp.2008.02.023","volume":"75","author":"Lee D.H.","year":"2008","unstructured":"Lee D.H.; Kim C.; Zhang L.; Lee Y.J.; Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 2008,75(10),2020-2033","journal-title":"Biochem Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12272-015-0671-y","volume":"39","author":"Oche B.","year":"2016","unstructured":"Oche B.; Chen L.; Ma Y.K.; Cryptotanshinone and wogonin up-regulate eNOS in vascular endothelial cells via ER\u03b1 and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via ER\u03b2. Arch Pharm Res 2016,39(2),249-258","journal-title":"Arch Pharm Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1874192401105010153","volume":"5","author":"Soski\u0107 S.S.","year":"2011","unstructured":"Soski\u0107 S.S.; Dobutovi\u0107 B.D.; Sudar E.M.; Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J 2011,5,153-163","journal-title":"Open Cardiovasc Med J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/labinvest.3700178","volume":"84","author":"Xin X.","year":"2004","unstructured":"Xin X.; Khan Z.A.; Chen S.; Chakrabarti S.; Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 2004,84(11),1451-1459","journal-title":"Lab Invest"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12020-010-9429-y","volume":"39","author":"Sun W.","year":"2011","unstructured":"Sun W.; Bi Y.; Liang H.; Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats. Endocrine 2011,39(3),235-241","journal-title":"Endocrine"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/aps.2015.37","volume":"36","author":"Zhang Y.M.","year":"2015","unstructured":"Zhang Y.M.; Li M.X.; Tang Z.; Wang C.H.; Wogonin suppresses osteopontin expression in adipocytes by activating PPAR\u03b1. Acta Pharmacol Sin 2015,36(8),987-997","journal-title":"Acta Pharmacol Sin"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/toxsci\/kfr180","volume":"123","author":"Wang X.","year":"2011","unstructured":"Wang X.; Son Y.O.; Chang Q.; NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium. Toxicol Sci 2011,123(2),399-410","journal-title":"Toxicol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.2337\/diacare.28.11.2686","volume":"28","author":"Tuttle K.R.","year":"2005","unstructured":"Tuttle K.R.; Bakris G.L.; Toto R.D.; McGill J.B.; Hu K.; Anderson P.W.; The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 2005,28(11),2686-2690","journal-title":"Diabetes Care"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T07:36:14Z","timestamp":1570692974000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173317\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":44,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,9,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612825666190708173108","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}